- This event has passed.
Psychedelic Capital July [ONLINE]
July 30 @ 10:00 am - 3:00 pm
About this Event
JULY 2020 EDITION / MONTHLY
July 30th / 1pm – 5pm / Toronto / Eastern Time
Looking at long term psychedelic drug discovery, the market for psychedelic clinics and how the two sectors will interact as the industry evolves.
Understanding how responsible go public tracks and sustainable IPO models will become key parts of the psychedelic investment ecosystem.
Tom Zuber – Zuber Lawler
Tyler Powell – FIVE Pharmaceuticals
Robert Laurie – Ad Lucem Law
Rick Doblin – MAPS
Richard Skaife – The Conscious Fund
Liana Gillooly – North Star
Lee Dorkin – Emprouen Advisors
Kris Miks – Norton Rose Fulbright
Henri Sant-Cassia – The Conscious Fund
Farrell Miller – NORML Canada
David Wood – Borden Ladner Gervais
Ashley Chiu – Ernst & Young
Andrew O’Donnell – Supercharged Stocks
Arron Victory – FIVE Pharmaceuticals
An investor conference series diving deep into psychedelic medicine investment. Each month, we present a curated group of CEOs, capital advisors, and investment luminaries from around the world.
Each session features two tracks. The first looks at the bigger picture, helping investors understand the psychedelic landscape. The second is a chance to hear from the hottest companies directly, in conversation with our experts.
The topics we explore include:
- Public Markets & IPOs
- Early Stage Opportunities
- Business & Operations
- Law & Regulation
- The Future